Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000248 · ClinicalTrials.gov registry record · Phase 3
Dose Response Trial of Pergolide for Cocaine Dependence - 1
A Phase 3 study of Cocaine-Related Disorders, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00000248: Completed Phase 3 study of Cocaine-Related Disorders, sponsored by Medical University of South Carolina.
NCT00000248 is a Phase 3 study of Cocaine-Related Disorders that has completed, run by Medical University of South Carolina. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000248, a Phase 3 study of Cocaine-Related Disorders, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
Conditions Studied
Interventions
- DRUG Pergolide
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-02 |
| Phase | Phase 3 |
What the finished NCT00000248 record still lists
NCT00000248 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Pergolide is the first listed.
NCT00000248 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00000248 about?
NCT00000248 is a clinical study titled "Dose Response Trial of Pergolide for Cocaine Dependence - 1". The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
What is the current status of trial NCT00000248?
This trial is currently completed. It is a Phase 3 study. The study started on 1996-02.
What conditions does trial NCT00000248 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders.
What interventions are being tested in trial NCT00000248?
The interventions under investigation include: Pergolide (DRUG).
Who is sponsoring clinical trial NCT00000248?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000248 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
-
Modeling Impaired Judgement in Cocaine Abusers - 6
COMPLETED · Phase 4
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
COMPLETED · Phase 2
-
Quetiapine for Cocaine Use and Cravings
COMPLETED · Phase 4
-
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
-
Pharmacological Modulation of Cocaine Effects - 1
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia